Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eucalyptus essence inhalation in hospitalized patients with COVID-19
IRCT20201127049507N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of eucalyptus oil in coronavirus disease 2019 (COVID-19), sponsored by Qom University of Medical Sciences. Started Sep 2021; status: completed.
02
Drugs
eucalyptus oil
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20201127049507N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201127049507N1.